Charles Bruce Green - 08 Apr 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Reporting relationship: Director
Issuer ticker: HUMA
Reported as of: 08 Apr 2025
Net transaction value: +$7,740
SEC form: 4
Accepted by SEC: 08 Apr 2025, 16:15:44 UTC
Prior SEC filing: 16 Sep 2024
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Charles Bruce Green by Dale A. Sander as Attorney-in-Fact

Key filing fact

Charles Bruce Green filed Form 4 for Humacyte, Inc. (HUMA) on 08 Apr 2025.

Key facts

This page summarizes Charles Bruce Green's Form 4 filing for Humacyte, Inc. (HUMA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Apr 2025, 16:15.

Change

Previous filing in this sequence was filed on 16 Sep 2024.
Current net transaction value: +$7,740.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUMA transaction

Common Stock

Purchase

Transaction value: $7,740
Shares: +6,000
Change %: +250%
Price: $1.29
Shares after: 8,400
Date: 08 Apr 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.285 to $1.2891. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.